The Lancet Haematology

The global community of researchers and clinicians working in the research and treatment of haematological disease needs a source of information that is authoritative, evidence-based, and clinically relevant. The Lancet Haematology will become that source, with practice-changing research articles, expert commentary, and provocative opinion in an online-only format. The topics in this journal will be broad, reflecting the breadth of the subject matter, focusing on research that advocates change in, or illuminates, haematological clinical practice. This will include haematology-oncology, red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, transfusion medicine, and related conditions and diseases. Although there have been great leaps towards in haematological research and patient care, there is still much work to be done, and we hope you will join us in delivering better health.

Editor in Chief: Dr. Lan-Lan Smith
2023
The Lancet Haematology
Global Print Circulation
5,000
Avg. Global Monthly Visits
18
Avg. Global Monthly Unique Visitors
18
Avg. Global Monthly Page Views
11
Avg. Global eTOC Distribution
47,951
Circulation updated on November 9, 2022. Circulation maintained at 5,000 from controlled subscribers and/or the inclusion of sponsored distribution. For additional information please contact your Elsevier Sales Representative eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023

Contacts

Display Advertising

Recruitment Advertising

Have a question or need assistance?

Contact us now and a Sales Representative will be in touch.